PULMOCIDE
Pulmocide Ltd, a company focused on the discovery and development of a new generation of inhaled medicines for the treatment of serious viral and fungal infections of the respiratory tract.
PULMOCIDE
Social Links:
Industry:
Biotechnology Health Care Health Diagnostics Medical Medical Device
Founded:
2013-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.pulmocide.com
Total Employee:
11+
Status:
Active
Contact:
+44 207 594 1210
Email Addresses:
[email protected]
Total Funding:
153.46 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
CeQur
CeQur develops and commercializes insulin delivery systems, giving people with type 2 diabetes freedom from multiple daily injections.
Edison Pharmaceuticals
Edison Pharmaceuticals develops medicines for the treatments of children and adults diagnosed with rare and neglected diseases.
Vero Biotech
Vero Biotech is a biopharmaceutical company developing products to address the medical needs of patients with pulmonary, cardiac diseases.
Injectsense
Monitoring therapy effectiveness (glaucoma) through miniaturized, autonomous in-vivo sensing and data uploading to cloud database.
Knopp Biosciences
Knopp Neurosciences is a drug discovery and development company working on treatments for neurological disorders.
NociTech
NociTech has developed a novel advanced pain test platform that enables a mechanism-based quantification of pain sensitivity.
Current Advisors List
Current Employees Featured
Founder
Investors List
Cystic Fibrosis Foundation
Cystic Fibrosis Foundation investment in Grant - Pulmocide
Jeito Capital
Jeito Capital investment in Series C - Pulmocide
Adjuvant Capital
Adjuvant Capital investment in Series C - Pulmocide
SV Health Investors
SV Health Investors investment in Series C - Pulmocide
F-Prime Capital
F-Prime Capital investment in Series C - Pulmocide
Johnson & Johnson Innovation – JJDC
Johnson & Johnson Innovation – JJDC investment in Series C - Pulmocide
SR One
SR One investment in Series C - Pulmocide
IP Group
IP Group investment in Series C - Pulmocide
Asahi Kasei Pharma
Asahi Kasei Pharma investment in Series C - Pulmocide
Longwood Fund
Longwood Fund investment in Series C - Pulmocide
Official Site Inspections
http://www.pulmocide.com Semrush global rank: 6.18 M Semrush visits lastest month: 1.3 K
- Host name: pulmocide.tempurl.host
- IP address: 45.76.139.2
- Location: London United Kingdom
- Latitude: 51.5128
- Longitude: -0.0638
- Timezone: Europe/London
- Postal: E1
